Table 3.
Individual and comorbid disorders predicting non-medical prescription opioid use and abuse/dependence.
| NMPOU
|
Abuse/Dep
|
|||||||
|---|---|---|---|---|---|---|---|---|
| n (%) | OR (95%CI) | AOR1 (95% CI) | n (%) | OR (95%CI) | AOR1 (95% CI) | |||
|
|
|
|
||||||
| No | Yes | No | Yes | |||||
| Referencea | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Axis I only | 205(1.41) | 41 (2.48) | 1.78 (1.20–2.64)** | 1.54(1.02–2.33)* | 36(0.25) | 13(0.83) | 3.29 (1.48–7.32)** | 2.69 (1.17–6.16)* |
| Axis II only | 205(1.41) | 77(2.98) | 2.14 (1.53–2.99)*** | 1.98 (1.41–2.77)*** | 36(0.25) | 33(1.15) | 4.60 (2.38–8.90)*** | 4.04 (2.09–7.78)*** |
| Axis III only | 205(1.41) | 85(1.13) | 0.80 (0.58–1.09) | 1.26 (0.92–1.75) | 36(0.25) | 23(0.33) | 1.29 (0.58–2.87) | 2.31 (1.09–4.89)* |
| Axis I +Axis II only | 205(1.41) | 65 (4.83) | 3.54 (2.58–4.85)*** | 2.77 (2.01–3.80)*** | 36(0.25) | 30(2.02) | 8.16 (4.44–14.99)*** | 6.10 (3.26–11.43)*** |
| Axis I +Axis III only | 205(1.41) | 30(2.43) | 1.74(1.04–2.91)* | 2.51 (1.44–4.38)** | 36(0.25) | 3(0.39) | – | – |
| Axis II + Axis III only | 205(1.41) | 29(2.03) | 1.45 (0.88–2.37) | 2.16 (1.27–3.65)** | 36(0.25) | 16(1.67) | 6.70 (3.12–14.39)*** | 11.44 (5.80–22.56)*** |
| Axis I+Axis II + Axis III | 205(1.41) | 39(3.55) | 2.57 (1.59–4.15)*** | 3.11 (1.94–4.97)*** | 36(0.25) | 28(2.90) | 11.80 (5.93–23.47)*** | 17.89 (9.28–34.47)*** |
a
Reference category, No Axis I, II or III; AOR1, adjusted for sex, age, marital status, education, household income, race; NMPOU, non-medical prescription opioid use; abuse/dep, opioid abuse and/or dependence; Axis I, past-year; Axis II, lifetime; Axis III, past-year. For prevalence rates, yes = percentage of individuals with the independent variable who have NMPOU or abuse/dependence, respectively; no = percentage of individuals with no Axis I, II or III who have NMPOU or abuse/dependence, respectively
*
p ≤ 0.05.
**
p ≤ 0.01.
***
p ≤ 0.001.